Siderophore–antibiotic conjugates: exploiting iron uptake to deliver drugs into bacteria

Clinical Microbiology and Infection

Volumn 24, Issue 8, 2018, Pages 801-802

  Schalk, I J ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFIDEROCOL; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; DANOMYCIN; GRISEIN; IRON CHELATING AGENT; MICROCIN; NORFLOXACIN; SALMYCIN; SIDEROMYCIN; SIDEROPHORE; SPIRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; IRON;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; BACTERIAL GROWTH; CONJUGATE; DRUG INDUSTRY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IRON HOMEOSTASIS; IRON TRANSPORT; MICROBIAL COMMUNITY; NONHUMAN; NOTE; PRIORITY JOURNAL; STREPTOMYCETACEAE; BACTERIUM; CHEMISTRY; DRUG EFFECT; HUMAN; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; IRON; MICROBIAL SENSITIVITY TESTS; SIDEROPHORES;

EID: 85046169624     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2018.03.037     Document Type: Note

References (9)

1. Hider, R., Siderophore mediated absorption of iron. Struct Bond, 58, 1984, 28.
2. Schalk, I.J., Mislin, G.L., Brillet, K., Structure, function and binding selectivity and stereoselectivity of siderophore-iron outer membrane transporters. Curr Top Membr 69 (2012), 37–66.
3. Klahn, P., Brönstrup, M., Bifunctional antimicrobial conjugates and hybrid antimicrobials. Nat Prod Rep 34 (2017), 832–885.
4. Mislin, G.L., Schalk, I.J., Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. Metallomics 6 (2014), 408–420.
5. Saisho, Y., Katsube, T., White, S., Fukase, H., Shimada, J., Pharmacokinetics, safety, and tolerability of cefiderocol, a novel siderophore cephalosporin for Gram-negative bacteria, in healthy subjects. Antimicrob Agents Chemother, 62, 2018.
6. Schalk, I.J., Guillon, L., Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways. Amino Acids 44 (2013), 1267–1277.
7. Gasser, V., Baco, E., Cunrath, O., August, P.S., Perraud, Q., Zill, N., et al. Catechol siderophores repress the pyochelin pathway and activate the enterobactin pathway in Pseudomonas aeruginosa: an opportunity for siderophore–antibiotic conjugates development. Environ Microbiol 18 (2016), 819–832.
8. Tomaras, A.P., Crandon, J.L., McPherson, C.J., Banevicius, M.A., Finegan, S.M., Irvine, R.L., et al. Adaptation-based resistance to siderophore-conjugated antibacterial agents by Pseudomonas aeruginosa. Antimicrob Agents Chemother 57 (2013), 4197–4207.
9. Kim, A., Kutschke, A., Ehmann, D.E., Patey, S.A., Crandon, J.L., Gorseth, E., et al. Pharmacodynamic profiling of a siderophore-conjugated monocarbam in Pseudomonas aeruginosa: assessing the risk for resistance and attenuated efficacy. Antimicrob Agents Chemother 59 (2015), 7743–7752.